BR9809493A - Modificação in vivo de galactomananas em guar por expressão de arn de anti-sentido de udp-galactose epimerase - Google Patents

Modificação in vivo de galactomananas em guar por expressão de arn de anti-sentido de udp-galactose epimerase

Info

Publication number
BR9809493A
BR9809493A BR9809493-9A BR9809493A BR9809493A BR 9809493 A BR9809493 A BR 9809493A BR 9809493 A BR9809493 A BR 9809493A BR 9809493 A BR9809493 A BR 9809493A
Authority
BR
Brazil
Prior art keywords
galactose
mannose
udp
expression
vivo modification
Prior art date
Application number
BR9809493-9A
Other languages
English (en)
Inventor
Morten Jorsboe
Janne Brunstedt
Steen Guldager Petersen
Original Assignee
Danisco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco filed Critical Danisco
Publication of BR9809493A publication Critical patent/BR9809493A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)

Abstract

Resumo da Patente de Invenção para <B>''MODIFICAçãO IN VIVO DE GALACTOMANANAS EM GUAR POR EXPRESSãO DE ARN DE ANTI-SENTIDO DE UDP-GALACTOSE EPIMERASE''<D> é descrito um processo de modificação in vivo. O processo afeta a razão manose para galactose de um organismo (ou parte do mesmo) capaz de produzir um composto contendo manose / galactose ou de um composto contendo manose / galactose do mesmo. O processo de modificação in vivo compreende a expressão de uma seq³ência de nucleotídeos que tem um efeito sobre: (a) a razão de manose para galactose de componentes de manose e de galactose de um composto contendo manose / galactose; e/ou (b) a razão manose para galactose de precursores de manose e de galactose para um composto contendo manose / galactose; e sendo que a seq³ência de nucleotídeos é de anti-sentido com relação a pelo menos uma parte do gene para uma enzima UDP-galactose epimerase.
BR9809493-9A 1997-05-28 1998-05-27 Modificação in vivo de galactomananas em guar por expressão de arn de anti-sentido de udp-galactose epimerase BR9809493A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710990.4A GB9710990D0 (en) 1997-05-28 1997-05-28 Modification process
PCT/IB1998/000891 WO1998054335A1 (en) 1997-05-28 1998-05-27 In vivo modification of galactomannans in guar by expression of udp-galactose epimerase antisense rna

Publications (1)

Publication Number Publication Date
BR9809493A true BR9809493A (pt) 2000-06-20

Family

ID=10813167

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809493-9A BR9809493A (pt) 1997-05-28 1998-05-27 Modificação in vivo de galactomananas em guar por expressão de arn de anti-sentido de udp-galactose epimerase

Country Status (10)

Country Link
EP (1) EP0983369A1 (pt)
JP (1) JP2002500515A (pt)
KR (1) KR20010012962A (pt)
CN (1) CN1264428A (pt)
AU (1) AU733483B2 (pt)
BR (1) BR9809493A (pt)
CA (1) CA2291449A1 (pt)
GB (2) GB9710990D0 (pt)
NZ (1) NZ500951A (pt)
WO (1) WO1998054335A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710990D0 (en) * 1997-05-28 1997-07-23 Danisco Modification process
ITPD980169A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
CA2359811C (en) * 1999-02-10 2010-12-21 E.I. Du Pont De Nemours And Company Udp-glucose modifiers
US6992236B1 (en) 1999-02-10 2006-01-31 E. I. Du Pont De Nemours And Company Plant UDP-glucose epimerases
GB9914210D0 (en) 1999-06-17 1999-08-18 Danisco Promoter
AU2003290793A1 (en) 2002-11-14 2004-06-15 Pioneer Hi-Bred International, Inc. Genes for galactomannan production in plants and methods of use
ITPD20050056A1 (it) 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
US7585818B2 (en) 2005-05-10 2009-09-08 Halliburton Energy Services, Inc. Nonnatural galactomannans and methods of use
JP2010520766A (ja) 2007-03-09 2010-06-17 コーニング インコーポレイテッド 細胞培養用三次元ガムマトリックス、製造方法および使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK198089D0 (da) * 1989-04-24 1989-04-24 Danske Spritfabrikker Dna-materialer og anvendelse deraf
GB9524752D0 (en) * 1995-12-04 1996-02-07 Danisco Modification process
GB9710990D0 (en) * 1997-05-28 1997-07-23 Danisco Modification process

Also Published As

Publication number Publication date
EP0983369A1 (en) 2000-03-08
GB2342920A (en) 2000-04-26
AU7446398A (en) 1998-12-30
KR20010012962A (ko) 2001-02-26
GB2342920B (en) 2001-08-15
CN1264428A (zh) 2000-08-23
CA2291449A1 (en) 1998-12-03
NZ500951A (en) 2001-09-28
AU733483B2 (en) 2001-05-17
GB9927197D0 (en) 2000-01-12
WO1998054335A1 (en) 1998-12-03
JP2002500515A (ja) 2002-01-08
GB9710990D0 (en) 1997-07-23

Similar Documents

Publication Publication Date Title
ATE541576T2 (de) 2&#39;-o,4&#39;-c-methylen bicyclonukleoside
EP2216407A3 (en) Therapeutic Compositions
MXPA02012010A (es) Oligodesoxinucleotidos inmunoestimulantes.
BR9809493A (pt) Modificação in vivo de galactomananas em guar por expressão de arn de anti-sentido de udp-galactose epimerase
EP1182206A3 (de) Stabiliserte Oligonucleotide und deren Verwendung
AU7621600A (en) Human rnase h and oligonucleotide compositions thereof
AU6589094A (en) 7-deazapurine modified oligonucleotides
AU5121399A (en) Rna targeted 2&#39;-modified oligonucleotides that are conformationally preorganized
BR0309145A (pt) Células das quais o genoma é modificado
EP0977767A4 (en) AMINOOXY-MODIFIED OLIGONUCLEOTIDES
PL328639A1 (en) Synthesis of p5&#39; phosphoamidane oligonucleotides n3&#39;
ATE196912T1 (de) Propargylethoxyamino nucleotide
Romano et al. Requirements for synthesis of ribonucleic acid primers during lagging strand synthesis by the DNA polymerase and gene 4 protein of bacteriophage T7.
BR9808963A (pt) Taqman tm-pcr para a detecção de cepas de e. coli patogênicas
BR9911491A (pt) Processo de tratamento de uma superfìcie metálica para aumentar a resistência contra corrosão, e, uso de uma solução de tratamento
DE69920247D1 (de) Veränderung der dns methyltransferase durch kombinationstherapie
BR9803727A (pt) Tintas biostáveis de base em água e processo para suas preparações.
GR3015527T3 (en) Anti-sense nucleotide sequence, anti RNA against alpha TNF messenger RNA, process for the preparation thereof, medical use thereof and its inclusion in pharmaceutical preparations.
CA2070664A1 (en) Antisense oligonucleotide inhibition of papillomavirus
WO1998032846A3 (en) Enzymatic nucleic acid treatment of diseases or conditions related to levels of c-fos
ATE266037T1 (de) Verfahren zur herstellung von phoshphorothioate triestere
DESCHÊNES et al. Nucleotides-1 to-4 of hepatitis delta ribozyme substrate increase the specificity of ribozyme cleavage
BR9807563A (pt) Composição útil na terapia gênica compreendendo partìculas de complexos agente (s) de transfecção catiÈnico (s) ácidos nucleicos estabilizados, e, processo para preparação da mesma.
BR0002493A (pt) Processo para a preparação de l-aminoácidos por fermentação e sequências de nucleotìdeos que codificam o gene accda
PA8467601A1 (es) Gen de streptomyces avermitilis que dirige la relacion de avermectinas b2:b1

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.